Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
28.9M
-
Shares change
-
-634K
-
Total reported value, excl. options
-
$936M
-
Value change
-
-$28.8M
-
Put/Call ratio
-
0.93
-
Number of buys
-
63
-
Number of sells
-
-91
-
Price
-
$32.38
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2020
199 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2020.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.9M shares
of 51.1M outstanding shares and own 56.5% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.03M shares), VANGUARD GROUP INC (3.54M shares), Redmile Group, LLC (2.34M shares), STATE STREET CORP (1.97M shares), JPMORGAN CHASE & CO (1.5M shares), DIMENSIONAL FUND ADVISORS LP (687K shares), GOLDMAN SACHS GROUP INC (638K shares), WS MANAGEMENT LLLP (636K shares), UBS Group AG (626K shares), and PERCEPTIVE ADVISORS LLC (508K shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.